key: cord-0875575-wia8500p
authors: Castagna, Alberto; Manzo, Ciro; Ruotolo, Giovanni
title: Comprensive Geriatric Assessment in hospitalized older patients with COVID‐19
date: 2020-12-01
journal: Geriatr Gerontol Int
DOI: 10.1111/ggi.14103
sha: 7ea242c1d2be0d55bc44134ecdbeb107c5787577
doc_id: 875575
cord_uid: wia8500p

nan

We read with great interest Sano et al.'s recent article in Geriatrics & Gerontology International entitled "COVID-19 in older adults: Retrospective cohort study in a tertiary hospital in Japan," which was about 26 patients with COVID-19 infection, admitted to tertiary and partner hospitals in Saitama, Japan. 1 We would like to reinforce the concept of geriatrics as a science of complexity characterized by the use of a specific assessment tool such as the Comprehensive Geriatric Assessment (CGA).

Indeed, it is common knowledge that the analysis of the data collected with the CGA is particularly useful and effective in the management of geriatric symptoms and syndromes, specifically in situations of complexity/emergency, the recent COVID-19 pandemic among these. 2 Among the indices used in the hospital setting, the Multidimensional Prognostic Index (MPI) has been identified as a wellcalibrated tool with a good discrimination and accuracy both for short-and long-term mortality. 3, 4 Moreover, the MPI is the only one based on information from a CGA that explores comprehensively not only health aspects, but also functional, cognitive and nutritional domains, as well as cohabitation status.

MPI total score is the sum of standardized and extensively validated rating scales, widely known by the clinicians 3 and expressing it as a score from 0 to 1. Three grades of MPI were identified: low risk, 0.0-0.33; moderate risk, 0.34-0.66; and severe risk, 0.67-1.0. 3 We identified 88 patients with COVID-19 consecutively admitted at "Pugliese-Ciaccio" General Hospital, Catanzaro, Italy, from March 15 to October 15, 2020. Twenty-seven (45.76%) patients were ≥65 years old with a mean AE SD age of 77.96 AE 8.71 years.

MPI was used. Delirium was evaluated using the 4AT. 5 The patients' demographic, clinical and CGA data are listed in Table 1 . The prevalence of delirium was 29.63%; with 0.0% for MPI-1 (low risk), 37.5% MPI-2 (moderate risk) and 62.5% MPI-3 (severe risk) (P < 0.000). The prevalence of in-hospital death was 25.98%; with 0.0% MPI-1 (low risk), 42.86% MPI-2 (moderate risk) and 57.14% MPI-3 (severe risk) (P < 0.004).

Following logistic binary regression analysis, delirium was associated with in-hospital death (P = 0.004), age (P = 0.001), Short Portable Mental Status Questionnaire (P = 0.000), activities of daily living (P = 0.028), Comorbidity Index Rating Scale (P = 0.001) and MPI (P = 0.000); and in-hospital death was statistically associated not only with delirium but also with the Short Portable Mental Status Questionnaire (P = 0.006), activities of daily living (P = 0.034) and MPI (P = 0.003).

In conclusion, our preliminary data highlighted that in hospitalized older patients with COVID-19, the risk of these negative outcomes (delirium and in-hospital death) significantly increases with the increase of MPI score. Therefore, we suggest that MPI should be routinely used as an example of GCA for identifying patients with potentially higher care needs and for planning better management of geriatric conditions. 

COVID-19 in older adults: retrospective cohort study in a tertiary hospital in Japan

Comment on: coronavirus 2019 in geriatrics and long-term care: the ABCDs of COVID-19

Development and validation of a multidimensional prognostic index for one-year mortality from comprehensive geriatric assessment in hospitalized older patients

Validation of a modified multidimensional prognostic index (m-MPI) including the mini nutritional assessment short-form (MNA-SF) for the prediction of one-year mortality in hospitalized elderly patients

Validation of the 4AT, a new instrument for rapid delirium screening: a study in 234 hospitalised older people

Comprensive Geriatric Assessment in hospitalized older patients with COVID-19

No funders had a role in writing the letter or the decision to submit for publication.

The authors declare no conflict of interest.

Giovanni Ruotolo 3